The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Relapses of Plasmodium vivax Infection Usually Result from Activation of Heterologous Hypnozoites
Open accessAbstract
BACKGROUND: Relapses originating from hypnozoites are characteristic of Plasmodium vivax infections. Thus, reappearance of parasitemia after treatment can result from relapse, recrudescence, or reinfection. It has been assumed that parasites causing relapse would be a subset of the parasites that caused the primary infection. METHODS: Paired samples were collected before initiation of antimalarial treatment and at recurrence of parasitemia from 149 patients with vivax malaria in Thailand (n=36), where reinfection could be excluded, and during field studies in Myanmar (n=75) and India (n=38). RESULTS: Combined genetic data from 2 genotyping approaches showed that novel P. vivax populations were present in the majority of patients with recurrent infection (107 [72%] of 149 patients overall [78% of patients in Thailand, 75% of patients in Myanmar {Burma}, and 63% of patients in India]). In 61% of the Thai and Burmese patients and in 55% of the Indian patients, the recurrent infections contained none of the parasite genotypes that caused the acute infection. CONCLUSIONS: The P. vivax populations emerging from hypnozoites commonly differ from the populations that caused the acute episode. Activation of heterologous hypnozoite populations is the most common cause of first relapse in patients with vivax malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tandem repeats finder: a program to analyze DNA sequences
Benson, G. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.573 · Cited by 9,374
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B., Marchesini, P., & Carter, R. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 970
Nested PCR Analysis of Plasmodium Parasites
Snounou, G., & Singh, B. (2003) · Malaria Methods and Protocols · doi:10.1385/1-59259-271-6:189 · Cited by 279
Self-citationResistance to Chloroquine by Plasmodium vivax in Irian Jaya, Indonesia
Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C., & Hoffman, S. L. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.44.547 · Cited by 232
Snounou, G., & Beck, H.-P. (1998) · Parasitology Today · doi:10.1016/s0169-4758(98)01340-4 · Cited by 215
Self-citationVivax malaria resistant to treatment and prophylaxis with chloroquine
Murphy, G. S., Basri, H., Andersen, E. M., Bangs, M. J., Gorden, J., Sorensen, K., Mount, D. L., Lal, A. A., Purwokusumo, A. R., Harjosuwarno, S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92568-e · Cited by 209
The assessment of antimalarial drug efficacy
White, N. J. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(02)02373-5 · Cited by 207
Self-citationTherapeutic Responses to Different Antimalarial Drugs in Vivax Malaria
Pukrittayakamee, S., Chantra, A., Simpson, J. A., Vanijanonta, S., Clemens, R., Looareesuwan, S., & White, N. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1680-1685.2000 · Cited by 174
Self-citationCATTAMANCHI, A., KYABAYINZE, D., HUBBARD, A., ROSENTHAL, P. J., & DORSEY, G. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.133 · Cited by 166
Cited by
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., Crabtree, J., Angiuoli, S. V., Merino, E. F., Amedeo, P., et al. (2008) · Nature · doi:10.1038/nature07327 · Cited by 835
Self-citationDeterminants of relapse periodicity in Plasmodium vivax malaria
White, N. J. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-297 · Cited by 679
Self-citationKey gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Mueller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & del Portillo, H. A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
Self-citationAntimalarial Drug Resistance: A Threat to Malaria Elimination
Menard, D., & Dondorp, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025619 · Cited by 499
Global Epidemiology of Plasmodium vivax
Howes, R. E., Battle, K. E., Mendis, K. N., Smith, D. L., Cibulskis, R. E., Baird, J. K., & Hay, S. I. (2016) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0141 · Cited by 418
Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology
Sato, S. (2021) · Journal of Physiological Anthropology · doi:10.1186/s40101-020-00251-9 · Cited by 404
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70855-2 · Cited by 388
Self-citationResistance to Therapies for Infection by Plasmodium vivax
Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-09 · Cited by 262
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Wells, T. N. C., Burrows, J. N., & Baird, J. K. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2009.12.005 · Cited by 262
Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria
Gowda, D., Dayananda, K., & Achur, R. (2018) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.234620 · Cited by 111
Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand
Rijken, M. J., Boel, M. E., Russell, B., Imwong, M., Leimanis, M. L., Phyo, A. P., Muehlenbachs, A., Lindegardh, N., McGready, R., Rénia, L., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-113 · Cited by 62
“Plasmodium vivax parasites were genotyped for three polymorphic markers: defined polymorphic regions in the genes encoding for the circumsporozoite surface protein (Pvcs), the merozoite surface protein 1 (Pvmsp1) or the merozoite surface protein 3a (Pvmsp3-a) [3,9,10] and for point mutations or copy number variation i…”
BackgroundMethodSelf-citationTarning, J., Chotsiri, P., Jullien, V., Rijken, M. J., Bergstrand, M., Cammas, M., McGready, R., Singhasivanon, P., Day, N. P. J., White, N. J., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-12 · Cited by 51
Self-citationThanapongpichat, S., McGready, R., Luxemburger, C., Day, N. P., White, N. J., Nosten, F., Snounou, G., & Imwong, M. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-275 · Cited by 32
“vivax infections in patients from Thailand, Myanmar and India are often polyclonal, and that the genotype of the parasites in the first relapse following chloroquine treatment [12] differs from that of the initial admission P.”
BackgroundSelf-citationBorrmann, S., Peto, T., Snow, R. W., Gutteridge, W., & White, N. J. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050227 · Cited by 15
Self-citationDombrowski, J. G., Acford-Palmer, H., Campos, M., Separovic, E. P. M., Epiphanio, S., Clark, T. G., Campino, S., & Marinho, C. R. F. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100407 · Cited by 5
Metadata
- Authors
- Imwong, M., Snounou, G., Pukrittayakamee, S., Tanomsing, N., Kim, J. R., Nandy, A., Guthmann, J., Nosten, F., Carlton, J., Looareesuwan, S., Nair, S., Sudimack, D., Day, N. P. J., Anderson, T. J. C., & White, N. J.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04
- Volume
- 195
- Issue
- 7
- Pages
- 927-933
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2124740902
- Cited by
- 294
- References
- 20
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.